Pfizer
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pfizer and other ETFs, options, and stocks.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
PFE News
Friday, May 10, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on...
Moderna (MRNA) stock skidded Friday after the Food and Drug Administration delayed an approval decision on its RSV vaccine until the end of the month. X The n...
Strengths highlight Pfizer's robust product portfolio and global market presence. Weaknesses underscore the challenges in revenue fluctuations and patent expir...
Analyst ratings
59%
of 27 ratingsMore PFE News
Prestige Consumer Healthcare (PBH) has issued an update. John F. Kelly, with an impressive 40-year tenure at Pfizer Inc., has been elected to the board of dire...
Loading... Loading... Pfizer Inc PFE has reportedly settled 10,000 lawsuits alleging it concealed the cancer risks associated with its Zantac heartburn medicat...
Loading... Loading... A young patient died due to cardiac arrest after receiving Pfizer Inc’s PFE experimental gene therapy in a mid-stage trial for Duchenne m...
Pfizer (PFE) stock jumped to its 50-day moving average in early May after the company beat first-quarter sales expectations, thanks to a one-time benefit for Co...
Pfizer (NYSE:PFE) has agreed to settle more than 10,000 lawsuits alleging that the company concealed cancer risks related to the discontinued heartburn drug Zan...
Pfizer (PFE) has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, Bloomberg’s Jef Feeley reports, ci...
Healthcare giant Pfizer (NYSE:PFE) paused a gene therapy trial for the treatment of Duchenne muscular dystrophy (DMD) following the sudden death of a young pati...